TG Therapeutics logo

TG Therapeutics

New York, New York, USA
387 Total Employees
Year Founded: 2011

Similar Companies Hiring

Machine Learning • Healthtech • Biotech • Big Data • Artificial Intelligence • Analytics
New York, NY
2482 Employees
Software • Pharmaceutical • Machine Learning • Healthtech • Biotech • Big Data • Artificial Intelligence
New York, NY
938 Employees
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
New York, NY
121990 Employees

TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).

TG Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
New York, New York, USA